These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Morrell A, Antony S, Kohlhagen G, Pommier Y, Cushman M. Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3659-63. PubMed ID: 15203138 [Abstract] [Full Text] [Related]
9. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL, Besterman JM, Brown HR, Evans MG, Leitner PP, Luzzio MJ, Shaffer JE, Sternbach DD, Uehling D, Vuong A. Cancer Res; 1995 Feb 01; 55(3):603-9. PubMed ID: 7834631 [Abstract] [Full Text] [Related]
10. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates. Gupta R, al-Said NH, Oreski B, Lown JW. Anticancer Drug Des; 1996 Jun 01; 11(4):325-38. PubMed ID: 8679055 [Abstract] [Full Text] [Related]
11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Bowman KJ, Newell DR, Calvert AH, Curtin NJ. Br J Cancer; 2001 Jan 05; 84(1):106-12. PubMed ID: 11139322 [Abstract] [Full Text] [Related]
14. [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I]. Li QY, Zhang Y, Yao LP, Fu YJ, Zu YG, Chen XQ, Zheng CY. Yao Xue Xue Bao; 2005 Dec 05; 40(12):1116-21. PubMed ID: 16496676 [Abstract] [Full Text] [Related]
15. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. Li Q, Zu Y, Shi R, Yao L, Fu Y, Yang Z, Li L. Bioorg Med Chem; 2006 Nov 01; 14(21):7175-82. PubMed ID: 16870453 [Abstract] [Full Text] [Related]
16. Synthesis and cytotoxic activity of new 9-substituted camptothecins. Dallavalle S, Rocchetta DG, Musso L, Merlini L, Morini G, Penco S, Tinelli S, Beretta GL, Zunino F. Bioorg Med Chem Lett; 2008 May 01; 18(9):2781-7. PubMed ID: 18434153 [Abstract] [Full Text] [Related]
17. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs. Lansiaux A, Léonce S, Kraus-Berthier L, Bal-Mahieu C, Mazinghien R, Didier S, David-Cordonnier MH, Hautefaye P, Lavielle G, Bailly C, Hickman JA, Pierré A. Mol Pharmacol; 2007 Aug 01; 72(2):311-9. PubMed ID: 17494837 [Abstract] [Full Text] [Related]
18. Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin. Lackey K, Sternbach DD, Croom DK, Emerson DL, Evans MG, Leitner PL, Luzzio MJ, McIntyre G, Vuong A, Yates J, Besterman JM. J Med Chem; 1996 Feb 02; 39(3):713-9. PubMed ID: 8576914 [Abstract] [Full Text] [Related]
19. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Wang LF, Ting CY, Lo CK, Su JS, Mickley LA, Fojo AT, Whang-Peng J, Hwang J. Cancer Res; 1997 Apr 15; 57(8):1516-22. PubMed ID: 9108454 [Abstract] [Full Text] [Related]